AARTIPHARM.BOAARTIPHARM.BOBSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank60
3Y CAGR+8.6%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+8.6%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$11.28B-20.8%
2024$14.25B-7.0%
2023$15.31B+74.1%
2022$8.80B-
2021$0.00-
2020$0.00-